# Targeted Prostate Cancer Screening in Men With BRCA1/2 Mutations

> **NCT07416812** · NA · COMPLETED · sponsor: **Institute of Oncology Ljubljana** · enrollment: 25 (actual)

## Conditions studied

- Prostate Cancer
- Hereditary Prostate Cancer

## Interventions

- **OTHER:** Targeted Prostate Cancer Screening
- **OTHER:** Telephone Follow-Up Interview

## Key facts

- **NCT ID:** NCT07416812
- **Lead sponsor:** Institute of Oncology Ljubljana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-29
- **Primary completion:** 2021-11-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07416812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07416812, "Targeted Prostate Cancer Screening in Men With BRCA1/2 Mutations". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07416812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*